Partner Content Partner Content An Update on PFS Quality Assurance and Manufacturing Process... PFS Quality Assurance and Manufacturing Processes
Partner Content Partner Content Ipsen presents on oral peptides innovations, advances and de... Ipsen presents on oral peptides innovations & delivery
Partner Content Partner Content PLIVA explores impact of EU Guidelines on evaluation of modi... PLIVA explores EU Guidelines for modified release drugs
Partner Content Partner Content Interview with GSK Ahead of Pre-Filled Syringes Europe 2018 Interview with GSK Ahead of Pre-Filled Syringes Europe
Partner Content Partner Content Pre-Filled Syringes: An Increased Focus on Safety and Human ... A spotlight on patient needs in parenteral drug deliver
Partner Content Partner Content SMi Group: Exclusive Speaker Interview with Professor Nagy H... RNA Therapeutics
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
